Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Macy’s, Inc. (M), Wal-Mart Stores, Inc. (WMT): Nordstrom, Inc. (JWN) Still Looks Good

When a lone boy cries wolf a few times in the dark, we learn a lesson about not lying. When a whole group of people collectively cry out, it might be a good idea to pay attention. Yesterday, Nordstrom, Inc. (NYSE:JWN) added its voice to the chorus of retailers warning of softer sales in at the end of the year. The department store chain increased its second-quarter profit, but still dropped its fiscal-year outlook. Here’s what investors need to know about Nordstrom’s performance and outlook.

Cutting costs and boosting sales

The 24% year-over-year increase in earnings per share was attributable to two main factors. First, Nordstrom, Inc. (NYSE:JWN) executed a quarter of “disciplined execution of inventory and expenses,” which helped boost the company’s operating margin. This quarter, Nordstrom, Inc. (NYSE:JWN) managed a 10.8% operating margin, up from 9.9% in the same quarter last year.

Nordstrom, Inc.

The second big factor in the quarter was the shift in the company’s annual sale. Last year, it ran in both the second and third quarters, which meant that sales in both periods were affected. Since the whole annual sale period was stuffed into the second quarter this year, the whole revenue boost came all at once. The company said that this will have a negative impact on third-quarter comparisons.

The dropped outlook

Nordstrom, Inc. (NYSE:JWN)’s management team believes that same-store sales growth has leveled off at a lower rate than expected. As a result, the company is forecasting that softness through the rest of the year, and now anticipates annual comparable-store sales to increase by only 2% to 3%. While it’s clearly disappointing for Nordstrom, Inc. (NYSE:JWN) investors, it’s not the first time we’ve heard this story this week.

Macy’s, Inc. (NYSE:M) announced a nice increase in earnings while also dropping its full-year outlook. The company cited a change in consumer attitudes as the driver for the decline. CFO Karen Hoguet said that it was Macy’s, Inc. (NYSE:M) belief that consumers were opting to spend their cash on cars, home improvements, and other non-department-store-based purchases. As earnings season plays out, the truth of that theory should become clearer.

Not to be outdone, Wal-Mart Stores, Inc. (NYSE:WMT) not only revised its forecast, it also posted a drop in comparable sales. The company said that it was feeling the pinch of little to no inflation in the cost of groceries combined with the squeeze of the 2% payroll tax.

The bottom line

Nordstrom seems well poised to finish off the year on track with its newly revised forecast. The business is growing its Rack line and continues to work toward its long-term goal of having 50% of revenue generated by Rack, online, and Canadian sales. While the drop in the comparable-store sales forecast is disheartening, I still have a rosy view of Nordstrom’s long-term health and success.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.